Breaking Finance News

Spire Healthcare Group (LON:SPI) target price held steady at 360.00GBX, reported today by Berenberg

Yesterday Spire Healthcare Group (LON:SPI) traded 0.82% higher at 328.90GBX. The company’s 50-day moving average is 328.19GBX and its 200-day moving average is 352.23GBX. The last stock close price is down -5.89% from the 200-day moving average, compared to the S&P 500 which has increased 0.06% over the same time. 596,674 shares of the stock were exchanged, up from an average trading volume of 526,043

Spire Healthcare Group (LON:SPI) had its stock price target hold steady to 360.00GBX by Berenberg in a report issued 02/09/2017. The updated price target implies a potential upside of 0.09% from the company's last stock close price.

Previously on 1/17/2017, Liberum Capital reported about Spire Healthcare Group (LON:SPI) lowered the target price from 440.00GBX to 400.00GBX. At the time, this indicated a possible upside of 0.28%.

See Chart Below

Spire Healthcare Group (LON:SPI)

Spire Healthcare Group has a 52 week low of 295.00GBX and a 52 week high of 411.00GBX with a PE ratio of 20.59 Spire Healthcare Group’s market capitalization is currently 0 GBX.

In addition to Berenberg reporting its stock price target, a total of 7 brokers have issued a research note on the company. The average stock price target is 57.14GBX with 1 broker rating the stock a strong buy, 4 brokers rating the stock a buy, 4 brokers rating the stock a hold, 0 brokers rating the stock a underperform, and finally 0 brokers rating the stock a sell.

Brief Synopsis On Spire Healthcare Group (LON:SPI)

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services. The Company offers a range of primary care, consulting and diagnostic services. The Company's serves a patient mix consisting of private medical insurance (PMI), self-pay and National Health Service (NHS) patients. The Company's primary activities include diagnostics, such as imaging, magnetic resonance imaging or computerized tomography scanning and pathology; out-patient services, such as consulting, treatments, health checks and physiotherapy, and in-patient daycase procedures, such as orthopedics, cardiology, neurology, oncology and general surgery.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.